AI Big-Data outfit Quantexa has appointed three industry luminaries to its Advisory Board.
These hires include Ralph Schlosstein, former CEO of Evercore and former President of BlackRock, Matthew Gould, former CEO of NHSX, and Sir Jeremy Fleming, Former Director of GCHQ.
Ralph Schlosstein, former CEO of Evercore and former President of BlackRock, brings decades of experience in investment banking to Quantexa’s Advisory Board. His career includes playing a strategic role in helping the world’s largest asset management firm go public. Ralph’s financial understanding will be pivotal in shaping corporate strategy initiatives.
Matthew Gould, former CEO of NHSX, joins Quantexa’s Advisory Board after serving as the British ambassador to Israel between 2010 and 2015, where Gould helped to launch the UK-Israel Technologies Hub – an initiative run in Tel Aviv to forge technology partnerships between UK and Israeli companies. More recently, Gould used his extensive background in healthcare to play a role in advising NHS on initiatives throughout the Covid-19 pandemic. At NHSX, Gould has been behind moves to use data and technology to improve healthcare delivery.
Sir Jeremy Fleming was the former Director of GCHQ and Deputy Head of MI5. He has more than 30 years of experience in intelligence and technology. His extensive background includes developing the National Cyber Security Centre, where he strived to make the UK the safest place to live and do business online. With a passion for making technology use in government more transparent, Sir Jeremy will enhance Quantexa’s capabilities in addressing emerging threats and opportunities.
The expansion of Quantexa’s Advisory Board comes at a pivotal time for the organisation, following the completion of a $129 million Series E funding round led by GIC, where Quantexa joined an elite group of UK tech companies reaching breakout unicorn status. It was announced this year that Quantexa will invest over $155 million in the global AI industry over the next three years to help clients advance the use of AI to protect, optimise, and grow their organisations. By 2027, Quantexa’s global investment in AI will reach more than $250 million.
Quantexa CEO Vishal Marria said that the three new hire’s collective expertise in finance, healthcare, and national security will be invaluable as the company develops cutting-edge decision intelligence solutions that address the market’s evolving needs.
